Prospects of siponimod in secondary progressive multiple sclerosis

被引:2
|
作者
McGinley, Marisa [1 ]
Fox, Robert J. [1 ]
机构
[1] Cleveland Clin, 9500 Euclid Ave,U-10, Cleveland, OH 44120 USA
关键词
D O I
10.1177/1756286418788013
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Siponimod in secondary progressive multiple sclerosis
    Rissardo, Jamir Pitton
    Caprara, Ana Leticia Fornari
    [J]. INTERNATIONAL ARCHIVES OF HEALTH SCIENCES, 2020, 7 (03) : 155 - 155
  • [2] Siponimod to treat secondary progressive multiple sclerosis
    Gajofatto, A.
    Turatti, M.
    [J]. DRUGS OF TODAY, 2020, 56 (01) : 37 - 46
  • [3] Siponimod for the treatment of secondary progressive multiple sclerosis
    Dumitrescu, Laura
    Constantinescu, Cris S.
    Tanasescu, Radu
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 143 - 150
  • [4] Siponimod for active secondary progressive multiple sclerosis
    Gaber, Tarek
    [J]. PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2021, 25 (02) : 4 - 5
  • [5] Siponimod: A Review in Secondary Progressive Multiple Sclerosis
    Lesley J. Scott
    [J]. CNS Drugs, 2020, 34 : 1191 - 1200
  • [6] Siponimod: A Review in Secondary Progressive Multiple Sclerosis
    Scott, Lesley J.
    [J]. CNS DRUGS, 2020, 34 (11) : 1191 - 1200
  • [7] Correction to: Siponimod: A Review in Secondary Progressive Multiple Sclerosis
    Lesley J. Scott
    [J]. CNS Drugs, 2021, 35 : 133 - 133
  • [8] Siponimod and Cognition in Secondary Progressive Multiple Sclerosis EXPAND Secondary Analyses
    Benedict, Ralph H. B.
    Tomic, Davorka
    Cree, Bruce A.
    Fox, Robert
    Giovannoni, Gavin
    Bar-Or, Amit
    Gold, Ralf
    Vermersch, Patrick
    Pohlmann, Harald
    Wright, Ian
    Karlsson, Goril
    Dahlke, Frank
    Wolf, Christian
    Kappos, Ludwig
    [J]. NEUROLOGY, 2021, 96 (03) : E376 - E386
  • [9] COST EFFECTIVENESS OF SIPONIMOD FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS IN TURKEY
    Tatar, M.
    Osbalas, T.
    Saracoglu, B.
    Olmez, C.
    Yarci, B.
    Akdernir, A. C.
    Yilmaz, C.
    Sen, S.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S184 - S184
  • [10] Safety and Tolerability of Siponimod in Patients with Secondary Progressive Multiple Sclerosis
    Fox, Robert
    Kappos, Ludwig
    Bar-Or, Amit
    Cree, Bruce
    Giovannoni, Gavin
    Gold, Ralf
    Vermersch, Patrick
    Pohlmann, Harold
    Wolf, Christian
    Dahlke, Frank
    Wallstrom, Erik
    Sidorenko, Tatiana
    [J]. NEUROLOGY, 2017, 88